Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Overview of the Vascular System01:20

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is increased size at birth associated with longevity on the population level? - A historical and comparative analysis of regions in Sweden.

Journal of developmental origins of health and disease·2021
Same author

Rare coding variants in 35 genes associate with circulating lipid levels-A multi-ancestry analysis of 170,000 exomes.

American journal of human genetics·2021
Same author

The probabilistic model of Alzheimer disease: the amyloid hypothesis revised.

Nature reviews. Neuroscience·2021
Same author

A possible association between early life factors and burden of functional bowel symptoms in adulthood.

Scandinavian journal of primary health care·2021
Same author

Effect of AMY1 copy number variation and various doses of starch intake on glucose homeostasis: data from a cross-sectional observational study and a crossover meal study.

Genes & nutrition·2021
Same author

District Differences in the Measured Values of Arterial Stiffness in Japan.

Circulation reports·2021

Related Experiment Video

Updated: Jun 29, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Early vascular aging (EVA): consequences and prevention.

Peter M Nilsson1

  • 1Department of Clinical Sciences Medicine, Lund University, University Hospital Malmö, Sweden. peter.nilsson@med.lu.se

Vascular Health and Risk Management
|October 2, 2008
PubMed
Summary

Biological age can differ from chronological age, impacting cardiovascular disease risk. Lifestyle changes and medications like statins may help prevent early vascular aging, with new drugs under investigation.

Keywords:
agingcardiovasculardiabeteshypertensionrisk factorsmokingvascular

More Related Videos

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
07:32

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Related Experiment Videos

Last Updated: Jun 29, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
07:32

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Area of Science:

  • Cardiovascular Medicine
  • Aging Research
  • Preventive Cardiology

Background:

  • A recognized discrepancy exists between chronological and biological age in patients.
  • This age disparity is evident in cardiovascular medicine, particularly in smokers exhibiting premature aging signs.
  • Vascular aging is a key target for cardiovascular risk factors, increasing the risk of early cardiovascular disease (CVD).

Purpose of the Study:

  • To explore the concept of biological aging in relation to cardiovascular disease.
  • To discuss current and emerging treatment modalities for preventing early vascular aging.
  • To highlight the role of lifestyle modifications and pharmacological interventions in managing vascular aging.

Main Methods:

  • Review of clinical observations and extrapolation to vascular function.
  • Discussion of established treatments like smoking cessation and statins.
  • Examination of novel drug classes (glitazones, rimonabant) and ongoing intervention studies.

Main Results:

  • Smoking accelerates biological aging, impacting vascular health and increasing CVD risk.
  • Lifestyle changes and existing medications (statins, RAS inhibitors) are crucial for prevention.
  • New drug classes show potential but require further evaluation due to side effects.

Conclusions:

  • Preventing early vascular aging is critical for reducing cardiovascular disease risk.
  • A combination of lifestyle interventions and pharmacotherapy is essential.
  • Ongoing research into new treatments holds promise for future CVD prevention strategies.